research

The Readout Meghana Keshavan

STAT Plus: Sanofi pours $1 billion into China for insulin plant

Health Theresa Gaffney

There’s an effective treatment for menopause symptoms. Why do so few women use it?

The Readout Meghana Keshavan

STAT Plus: Despite probe, China reimbursing AstraZeneca drug

The Readout Meghana Keshavan

STAT Plus: The biotech news you need to read today

Health Rachel Cohrs Zhang

STAT Plus: Trump picks Stanford’s Jay Bhattacharya to lead NIH

In the Lab Andrew Joseph

STAT Plus: New report urges guidelines — and some restrictions — on stem cell-based embryo models

The Readout Adam Feuerstein

STAT Plus: Roche’s TIGIT troubles continue, a novel Alzheimer’s target misses the mark, and other biotech news

The Readout Meghana Keshavan

STAT Plus: What to make of Trump’s health care nominees

In the Lab Jonathan Wosen

STAT Plus: Trump’s promise to reinstate travel bans has scientists deeply concerned

Politics John Wilkerson

STAT Plus: Rand Paul plans to investigate Covid-19 origins from his new perch leading a key committee

The Readout Meghana Keshavan

STAT Plus: More beef in the gene editing space

Morning Rounds Theresa Gaffney

Squid-inspired replacements for needles; Science Twitter and Bluesky

The Readout Meghana Keshavan

STAT Plus: Versant enters obesity with new startup

Health tech Katie Palmer

STAT Plus: Bluesky is the new destination for X/Twitter’s health and science community. Here’s why

The Pharmalot View Ed Silverman

STAT Plus: RFK Jr. wants to blow up the ‘corrupt’ FDA, but he could Make America Sick Again

In the Lab Anil Oza

A new device for delivering drugs without needles draws inspiration from the elegant squid

The Readout Meghana Keshavan

STAT Plus: Investors tell Silence Therapeutics to shush 

Pharma Matthew Herper

STAT Plus: Doubling down on its strategy, Pfizer names its head of oncology as new research chief

The Readout Meghana Keshavan

STAT Plus: A win for Apellis, a setback for Astellas

Biotech Matthew Herper and Allison DeAngelis

STAT Plus: Former NCI chief and serial biotech entrepreneur raise $70 million to start companies that fail fast

The Readout Meghana Keshavan

STAT Plus: Novartis ramps up in radiopharma, and Eli Lilly adds Zepbound details

Health Adam Piore — Boston Globe

STAT Plus: Mass General doctor reveals cause of death of historic pig kidney transplant patient

The Readout Meghana Keshavan

STAT Plus: CAR-T promising for autoimmune disease while perhaps preserving fertility

Health Jason Mast

STAT Plus: ‘Worst imaginable’ brain tumor yields, in some young people, to CAR-T therapy

The Readout Elaine Chen

STAT Plus: Amgen defends obesity drug amid bone concerns

The Readout Elaine Chen

STAT Plus: BioNTech acquires its Chinese cancer drug partner

Health Anil Oza

With a push from RFK Jr., baseless fears about fluoride go mainstream

Politics Lizzy Lawrence

STAT Plus: FDA commissioner suggests RFK Jr. and Trump might compromise an agency ‘at peak performance’

The Readout Elaine Chen

STAT Plus: When even an ‘over the wall’ PIPE can’t help